Market gets 'saffron' rush; Sensex ends 250 points higher

It's the hope rally that pushed frontline stocks to higher levels on Thursday. Markets remained exuberant after a gap-up opening but came off its peak as the day progressed as investors booked......

US FDA tightens regulatory noose on Indian drug firms

Import alert on Ranbaxy’s Mohali unit; Strides’ injectible arm gets warning letter Indian drug makers have again come under the scrutiny of the US Food and Drug Administration (US FDA),......

Sun Pharma slumps after $550 mn patent suit settlement with Pfizer

Shares of Sun Pharmaceuticals on Thursday  fell sharply by nearly 7 per cent in early trade, after the pharmaceutical major and Israel's Teva agreed to pay a sum of $2.15 billion to Pfizer......

Indian firms eye $2.5-bn US drug market

Indian pharmaceutical majors are set to tap the generic anti-depressant market in the US, the largest pharma market in the world. The anti-depressant drug market in the US is primarily ruled by......